Inhibition of phosphatidylinositol 3‐kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells

International Journal of Cancer (2003) - Comment
doi: 10.1002/ijc.11085 issn: 0020-7136 issn: 1097-0215 pubmed: 12704666

Manuela Klingler-Hoffmann, Patricia Bukczynska, Tony Tiganis